BMRA insider trading
NasdaqCM HealthcareBIOMERICA INC: insider trade history from SEC Form 4 filings.
About BIOMERICA INC
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. The company has strategic partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs for launching the inFoods platform in Canada. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Company website: www.biomerica.com
BMRA insider activity at a glance
FilingIQ tracks 164 insider transactions for BMRA in filings since May 11, 2015. The most recent transaction is dated Aug 26, 2026.
Across the full history, 95 open-market purchases
and 18 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on BMRA insider trades is 59.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest BMRA Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for BMRA?
- FilingIQ tracks 164 Form 4 insider transactions for BMRA (BIOMERICA INC), covering filings from May 11, 2015 onwards. 5 of those are dated within the last 90 days.
- Are BMRA insiders net buyers or net sellers?
- Across the full Form 4 history for BMRA, 95 transactions (58%) were open-market purchases and 18 (11%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does BMRA insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is BMRA in?
- BIOMERICA INC (BMRA) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $6.56M.
Methodology & sources
Every BMRA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.